Operating Lease, Right-of-Use Asset of RIGEL PHARMACEUTICALS INC from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
RIGEL PHARMACEUTICALS INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • RIGEL PHARMACEUTICALS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,050,000, a 159% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

RIGEL PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,050,000 +$645,000 +159% 30 Sep 2025 10-Q 04 Nov 2025 2025 Q3
Q2 2025 $1,178,000 +$618,000 +110% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,305,000 +$593,000 +83% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $246,000 -$615,000 -71% 31 Dec 2024 10-Q 04 Nov 2025 2025 Q3
Q3 2024 $405,000 -$603,000 -60% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $560,000 -$437,000 -44% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $712,000 -$411,000 -37% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $861,000 -$1,069,000 -55% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $1,008,000 -$1,983,000 -66% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $997,000 -$4,248,000 -81% 30 Jun 2023 10-Q 01 Aug 2023 2023 Q2
Q1 2023 $1,123,000 -$6,409,000 -85% 31 Mar 2023 10-Q 02 May 2023 2023 Q1
Q4 2022 $1,930,000 -$7,773,000 -80% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $2,991,000 -$8,833,000 -75% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $5,245,000 -$8,650,000 -62% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $7,532,000 -$8,387,000 -53% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $9,703,000 -$8,192,000 -46% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $11,824,000 -$8,049,000 -41% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 $13,895,000 -$8,016,000 -37% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $15,919,000 -$7,856,000 -33% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $17,895,000 -$7,814,000 -30% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $19,873,000 -$7,773,000 -28% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $21,911,000 -$7,498,000 -25% 30 Jun 2020 10-Q 04 Aug 2020 2020 Q2
Q1 2020 $23,775,000 -$7,361,000 -24% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 $25,709,000 31 Dec 2019 10-K 02 Mar 2021 2020 FY
Q3 2019 $27,646,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $29,409,000 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $31,136,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.